Literature DB >> 23717099

Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.

Dong-Hyun Kim1.   

Abstract

The major commercial ginsengs are Panax ginseng Meyer (Korean ginseng), P. quinquifolium L. (American ginseng), and P. notoginseng (Burk.) FH Chen (Notoginseng). P. ginseng is the most commonly used as an adaptogenic agent and has been shown to enhance physical performance, promote vitality, increase resistance to stress and aging, and have immunomodulatory activity. These ginsengs contain saponins, which can be classified as dammarane-type, ocotillol-type and oleanane-type oligoglycosides, and polysaccharides as main constituents. Dammarane ginsenosides are transformed into compounds such as the ginsenosides Rg3, Rg5, and Rk1 by steaming and heating and are metabolized into metabolites such as compound K, ginsenoside Rh1, protoand panaxatriol by intestinal microflora. These metabolites are nonpolar, pharmacologically active and easily absorbed from the gastrointestinal tract. However, the activities metabolizing these constituents into bioactive compounds differ significantly among individuals because all individuals possess characteristic indigenous strains of intestinal bacteria. To overcome this difference, ginsengs fermented with enzymes or microbes have been developed.

Entities:  

Keywords:  Biotransformation; Constituents; Panax ginseng; Panax notoginseng; Panax quinquifolium

Year:  2012        PMID: 23717099      PMCID: PMC3659563          DOI: 10.5142/jgr.2012.36.1.1

Source DB:  PubMed          Journal:  J Ginseng Res        ISSN: 1226-8453            Impact factor:   6.060


INTRODUCTION

The term ginseng refers to the dried roots of several plants of the species Panax sp. (Family Araliaceae). The three major commercial ginsengs are P. ginseng Meyer (Korean ginseng), which has been used as an herbal medicine for more than 2000 years [1], P. quinquifolium L. (American ginseng), and P. notoginseng (Burk.) FH Chen (Notoginseng) [2,3]. These ginsengs have been used worldwide for thousands of years as either food or herbal medicines. P. ginseng has been the most commonly used as an adaptogenic agent and has been shown to enhance physical performance, promote vitality, increase resistance to stress and aging, and have immunomodulatory activity [4,5]. The roots of these ginsengs have been used as herbal medicines in Asian countries, and their bioactive chemicals have been isolated. In 1854, Garriques performed the first chemical studies on ginseng [6] and separated a saponin fraction from P. quinquifolium. Despite these findings, the components of ginseng were not studied again until 1963. Shibata et al. [7], Shibata et al. [8], and Shibata et al. [9] isolated ginseng saponins from the root of P. ginseng and identified their structures in 1963. These saponins were called ginsenosides. Since the reports of Shibata et al., many researchers have isolated the components of Korean ginseng, American ginseng, and Notoginseng. Today, approximately 200 substances, such as ginsenosides, polysaccharides, polyacetylenes, peptides, and amino acids, have been isolated from Korean ginseng [2], and more than 100 substances have been isolated from American ginseng and Notoginseng. Among the substances isolated from ginseng, the major and most unique components are the ginseng saponins (ginsenosides), which can be classified as dammarane-type, ocotillol-type and oleanane-type oligoglycosides (Fig. 1), and polysaccharides [10]. Furthermore, the dammaranetype saponins are classified into protopanaxadiol and protopanaxatriol types. The protopanaxadiol-type has sugar moieties attached to OH at C-3 and/or C-20, and the protopanaxatriol-type has sugar moieties attached to OH at C-3, C-6, and/or C-20. The ocotillol-type has a five-membered epoxy ring at C-20, and the oleanane-type has a modified C-20 side chain. With the development of instrumental analysis, minor constituents are constantly being isolated from these ginsengs.
Fig. 1.

The structures of representative ginseng saponins. PPD, protopanaxadiol; PPT, protopanaxatriol.

Chemically, several differences exist among Korean ginseng, American ginseng, and Notoginseng. An important parameter used for differentiation is the presence of the ginsenoside Rf in Korean ginseng and Notoginseng, the pseudoginsenoside F11 in American ginseng [11], and the notoginsenoside R1 in Korean ginseng and Notoginseng. In addition, the ratio of Rg1/ Rb1 has been widely used to differentiate between these ginsengs. Ratios of less than 0.4 are indicative of American ginseng, whereas a high value ratio is characteristic of Korean ginseng and Notoginseng [12]. Although notoginsenosides are not isolated from the root of Korean ginseng, many notoginsenosides are found in Notoginseng (Table 1).
Table 1.

Comparison of typical ginsenoside composition of Korean ginseng (Panax ginseng), American ginseng (P. quinquefolius) and Notoginseng (P. notogisneng)

Chemical compositionKorean ginsengAmerican ginsengNotoginseng

Major ginsenosidesRb1, Rg1, Rb2Rb1, Re, RdRb1, Rg1, Ra3, R1
PPD-group to PPT-group<2.0>2.0<2.0
Rb1: Rg1<5.0>5.0<1

PPD, protopanaxadiol; PPT, protopanaxatriol.

Comparison of typical ginsenoside composition of Korean ginseng (Panax ginseng), American ginseng (P. quinquefolius) and Notoginseng (P. notogisneng) PPD, protopanaxadiol; PPT, protopanaxatriol. Recent studies have reported the constituents of the roots of Korean ginseng, American ginseng and Notoginseng as well as their leaves and stem, flower buds, and fruits. Based on these findings, the leaves and stem, flower buds, fruits, and roots have recently been used as functional food, cosmetics, and herbal medicines. Furthermore, immunopotentiating polysaccharides have been isolated from these ginsengs. Acidic polysaccharides are more abundant in Korean ginseng compared with those in American ginseng and Notoginseng. However, the structures of many polysaccharides that are isolated from ginsengs have not been clearly identified.

CHEMICAL DIVERSITY OF PANAX GINSENG

Today, approximately 200 substances, such as ginsenosides, polysaccharides, polyacetylenes, peptides, and amino acids, have been isolated from Korean ginseng [2]. Of these, ginsenosides and polysaccharides are the major and most unique constituents.

Saponins

Saponins are the major constituents isolated from the root of Korean ginseng. Because P. ginseng has been historically used as an herbal medicine, extensive chemical studies have focused on the root of P. ginseng. Recent studies are focusing on the constituents of the leaves and stem, flower buds, fruits, and roots of ginseng and their pharmacological activities. Since Shibata et al. isolated prosapogenins in 1963, many kinds of saponins have been isolated from its roots, leaves and stem, flower buds, fruits, and seeds. Shibata et al. [7] established the chemical structures of main the prosapogenins 20Sprotopanaxadiol, 20S-protopanaxatriol, prosapgenin, and ginsenoside Rg1, which were extracted from the dried root of ginseng [8,9,13]. Kitagawa et al. [14] and Kitagawa et al. [15] isolated malonyl ginsenosides Rb1, Rb2, Rc, and Rd from the dried root of ginseng. Subsequently, the ginsenosides Ro, Ra1, Ra2, Ra3 Re, Rf, Rg1, Rg2, Rg3, Rh1, the notoginsenosides R4, 20-gluco-ginsenoside Rf, koryoginsenoside R1, and R2, and the ginsenosides Rb1, Rb2, Rc, and Rd, have been reported [11,16]. Recently, Ruan et al. [17] isolated the malonylginsenoside Ra3 from the root of P. ginseng. Zhu et al. [18] isolated 6 new protopanaxatriol-type ginsenosides, the ginsenosides Re1, Re2, Re3, Re4, Re5, Re6, and 10 known protopanaxatriol ginsenosides, including the ginsenoside Rg1 from the root of P. ginseng. Approximately one thousand years ago, red (steamed) ginseng was developed to enhance the storage and the pharmacological effect of ginseng in Korea. Until recently, red ginseng had been widely made and largely consumed. Many scientists have isolated and identified its constituents to understand the pharmacological activities and bioactive components of red ginseng. Hiromichi et al. [19] isolated the ginsenosides Ra1, Ra2, and Ra3, and the notoginsenoside R4 from the steamed root of ginseng (red ginseng). Kasai et al. [20] isolated the ginsenosides Ra1, Ra2, Ra3, Rs1, and Rs2, the notoginsenoside R1, and the quinquenoside R1. Thereafter, the ginsenosides Ro, Rb1, Rb2, Tc, Rd, Re, Rf, Rg1, Rg2, Rg3, Rh1, the ginsenosides Rh2, 20R-ginsenoside Rh1, 20S-ginsenoside Rg3, and 20R-ginsenoside Rg2 were isolated from red ginseng. Ryu et al. [21] isolated the ginsenoside Rg6 and 20(E)-ginsenoside F4 from red ginseng. Baek et al. [22] isolated the ginsenoside Rh4. Then, the ginsenosides Rs1, Rs2, Rs3, and Rs4, the quinoginsenoside R4, the ginsenosides Rg3, Rg5, Rg6, F4, and Rf2 were isolated from red ginseng [23,24]. In particular, large quantities of the ginsenosides Rh1, Rg3 and Rg2 were found in red ginseng. Under intense steaming or heating, ginsenoside Rg3 may be further transformed to 20S-Rh2 and 20R-Rh2, and these ginsenosides subsequently become aglycone 20S-protopanaxadiol, 20R-protopanaxadiol, or even 20-dehydroprotopanaxadiol through chemical degradation. Ginsenosides Rk1 and Rg5 are again transformed into the degradation products Rk2 and Rh3. Rh1 can be changed into the aglycones 20S-protopanaxatriol, 20R-protopanaxatriol, and 20-dehydropropanaxatriol. Shoji et al. [25] and Shoji et al. [26] were interested in the constituents of the leaves of P. ginseng. They isolated the ginsenosides Rb1, Rb2, Rc, Rd, Re, Rg1, F1, F2, and F4 from the leaves and stems. The ginsenosides F4, 20R-protopanaxadiol, 20R-protopanaxatriol, ginsenoside Rh3, 20R-ginsenoside Rh2, 20S-ginsenoside Rh2, ginsenosides Rh1, Rg3, Rg2, Rg1, Re, Rd, Rc, Rb2, and Rb1 were isolated from the flower buds of P. ginseng [27]. Ginsenosides Rh5, Rh6, Rh7, Rh8, Rh9 and Rg7, the majoroside F1, F2, the notoginsenoside Fe, the majoroside F4, and chikusetsusaponin L8 were also isolated [28,29]. Recently, Tung et al. [30] isolated two new ginsenosides Ki and Km from the leaves of P. ginseng. Liu et al. [31] isolated three new ginsenosides, 20S-3β,6α,12b-,20-tetrahydroxydammara-25-ene-24- one 20-O-β-glucopyranoside, 20S-3β,6α,12β-,20,24,25-pentahydroxydammarane 20-O-β-D-glucopyranoside, 20S,23E-3β,6α,12b,20,25-tetrahydroxydammara-23-ene 20-O-β-glucopyranoside and six known compounds from the leaves of P. ginseng. Wu et al. [32] isolated 3β,6α,12β-triol-22,23,23,25,26,27-hexanordammaran- 20-one and dammar-20(22),24-diene-3β,6α,12β-triol from the leaves of P. ginseng. Huang et al. [33] isolated new 20R,22(xi),24(S)-dammar-25(26)-ene-3β,6α,12β,20,22,24-hexanol from the leaves of P. ginseng [34]. Tung et al. steamed the leaves of P. ginseng, and then investigated their constituents. They isolated new ginsenosides: SL-1, SL-2, SL3, and 11 known compounds [35]. Shoji et al. [26] also investigated the constituents of the flower buds of P. ginseng. They isolated ginsenosides Rb1, Rb2, Rc, Rd, Re, Rg1, F3, and M7cd from the flower buds of P. ginseng. They also isolated ginsenosides Rb2, Rd, Rd, Re, Rg2, 20R-protopanaxatriol, 20Rginsenoside Rh1, 20R-ginsenoside Rg2, notoginsenoside-E, and gypenoside XVII from the flower buds of P. ginseng [25]. Yoshikawa et al. [36] isolated new floralginsenosides A, B, C, D, E, and F from the flower buds of P. ginseng. They also isolated new floralginsenosides-M, N, O, and P and the ginsenosides Rd and Re [37]. Nguyen et al. [38] isolated new floralginsenosides-Ta, Tb, Tc, and 6 known dammarane-type saponins from the flower buds of P. ginseng. Tung et al. [39] isolated antioxidant floralginsenosides Ka, Kb, and Kc from the flower buds of P. ginseng. Floralginsenosides Ka-Kc and majoroside F1 were also isolated from the flower buds of P. ginseng [39]. Recently, many researchers have been interested in the fruits and seeds of P. ginseng. Zhao et al. [40] isolated three new ginsenosides, 20R-25 methoxyldammarane-3β,6α,12β,20-triol, 20R-25-methoxyldammarane-3β,6α,12b,20-tetrol, and 20R-20,25 dimethoxyldammarane-3β,6α,12b,20-diol, and 2 known ginsenosides from the fruit of P. ginseng. Sugimoto et al. [41] isolated a new type of saponin, called panaxadione, from the seeds of P. ginseng.

Polysaccharides

Many kinds of polysaccharides have been isolated from Korean ginseng. For example, Konno et al. [42], Konno et al. [43], and Ohshima et al. [44] isolated the hypoglycemic glycans, panasans A - E, poanaxans F - H, panaxans I - L, panaxans M - P, and panaxans Q - U from the root of P. ginseng. Tomoda et al. [45] and Tomoda et al. [46] isolated the immunomodulating glycans ginsenan PA and ginsenan PB from the root of P. ginseng. These immunomodulationg glycans are composed of L-arabinose, D-galactose, L-rhamnose, D-galacturonic acid, and D-glucuronic acid. However, the intact structures of these glycans have not been identified. Immunomodulating glycans, such as acidic polysaccharide ginsenan S-IA and ginsenan S-II A (MW 5.6×104, 1.0×105), have been continually reported.

Others

Favonoids and polyacetylenes, such as kaempferol, trifolin and panasenoside, were also isolated from the roots of P. ginseng. Matsunaga et al. [47] isolated polyacetylenes, panaxynol, and panaxydol. Iwabuchi et al. [48] isolated two sesquierpene alcohols, pansinsanol A and panasinsanol B. Sesquiterpene hydrocarbons, α-panasinene, β-panasinsene, α-neoclovene, and β-panasinsene were also isolated from the rootlet. Furthermore, two new sesquitene alcohols, ginsenol and senecrassidiol, were found [49,50]. In addition, ginsenoynes A, B, C, D, E, F, G, H, I, J, and K have been reported.

CHEMICAL DIVERSITY OF PANAX QUINQUIFOLIUM

American ginseng (P. quinquifolium L., family Araliaceae), a plant native to North America, is now cultivated in many countries. P. quinquifolium also contains saponins, flavonoids, polyacetylenes, polysaccharides, amino acids, fatty acids, and peptides. Saponins, particularly ginsenosides, are constituents of American ginseng (P. quinquifolium). More than 60 ginsenosides, including dammarane-, ocotillol-, and oleanane-types, have been isolated from the roots, leaves, stems, flower buds and berries of P. quinquifolium. Chen et al. [51] isolated quiquenosides L10 and L16 from the leaves and stems of P. quinquifolium. Jiang et al. [52] isolated two new saponins, 3β,12β,20S trihydroxydammar- 23-ene-3-O-{[β-D-glucopyranosyl(1->2)-β-Dglucopyranosyl]- 20-O-[α-L-arabinopyranosyl(1->)]-β- D-glucopyranoside and 3β-20S-dihydroxy-12β-23Repoxydammar- 24-ene-3-O-{[β-D-glucopyranosyl(1- >2)-β-D-glucopyranosyl]-20-O-[β-D-xylosyl(1->6)]-β- D-glucopyranoside from the leaves of P. quinquifolium. Many ginsenosides have been isolated from P. quinquifolium. Protopanaxadiol-type ginsenosides isolated from the roots, leaves and stems, and flower buds of American ginseng are the ginsenosides Rb1, Rc, Rb2, Rb3, Rd, Rg3, F2, Rs1, quinquenosides I, II, III, V, L10, L14, pseudoginsenosides RC1, F8, and gypenoside XVII [51-56]. Protopanaxatriol-type ginsenosides found in American ginseng are the ginsenosides Rg1, Rg2, Re, Rg2, F3, Ia, F1, Rh1, 20S-acetyl ginsenoside Rg2, 20Racetyl ginsenoside Rg2, floralquinquenoside E, 20Rginsenoside Rg2, Rh1, 20S-protopanxatriol, and 20Rprotopanaxatriol [52,54,56]. Du et al. [57] isolated four malonyl-ginsenosides, Rb1, Rc, Rb2, and Rd. In addition, the minor ginsenosides 4 ocotillol-type ginsenosides (24Rpseudoginsenoside F11, pseudoginsenoside RT5, F-11, 24R-vina-ginsenoside R1), 2 oleanane-type ginsenosides (ginsenoside Ro, chikusetsusaponin Iva), and 3 dammarane saponins with a modified steroid skeleton (vinaginsenoside R3, quinquenoside IV, and notoginsenoside G) were isolated from P. quinquifolium [54,56]. Minor saponins modified in C-20 side-chain (quinquenosides L1, L2, L8, L11, L3, L7, L9, L16, I, gypenosides LXIX, LXXI, majoroside-F1, notoginsenosides A, C, E, K, ginsenosides I, III, vina-ginsenoside R8, floralquinquenosides B, D, A, C, quinquefolosides La, Lc) were also isolated [52,54,58]. American red ginseng was also experimentally prepared under the same steam and heat treatments as Korean ginseng [59]. Then, the chemical composition of American red ginseng was studied. The constituents of the steamed American ginseng were largely different from those of the untreated ginseng. The steaming process induced obvious chemical degradation and conversion of original saponins to some newly occurring compounds. The polar ginsenosides, including Rg1, Re, Rb1, Rc, Rb2, Rb3, and Rd, decreased remarkably; however, less polar ginsenosides, including Rg2, Rg3, Rg5, Rh2, Rk1, and Rs4, increased [60,61]. The 20S and 20R-ginsenoside are typical stereoisomers formed by the selective attack of the hydroxyl group after elimination of the glycosyl residue at C-20. Additionally, Rk1/ Rg5 and Rk3/Rh4, isomers of the double bond at C-20/21 or C-20/22, were identified. This result was similar to the transformation of ginsenosides seen in Korean red ginseng. Nakamura et al. [54] isolated five new dammaranetype triterpene glycosides, floralquinquenosides A, B, C, D, and E, and 18 known dammarane-type triterpene glycosides, ginsenoside Rb3, ginsenoside Rd, ginsenoside Rs1, pseudo-ginsenoside-RC1, pseudo-ginsenoside- F8, quinquenoside III, ginsenoside I, notoginsenoside- E, ginsenoside Re, ginsenoside Rg1, ginsenoside Rg2, ginsenoside-F3, ginsenoside Ia, quinquenoside L9, pseudo-ginsenoside RT5, pseudo-ginsenoside F11, and 24(S)-pseudo-ginsenoside F11 from the flower buds of P. quinquifolium L. Qiu et al. [62] isolated a new saponin quinquefoloside-L(c) (3β,12β,20Strihydroxy- 25-methoxy-25-methoxydammar-23-ene-3-O-β-Dglucopyranosyl( 1->2)β-D-glucopyranosyl-20-O-β- xylopyranosyl(1->6)-β-D-glucopyranoside) from the leaves of P. quinquifolium. This saponin was found to be cytotoxic against tumor cells. Many kinds of polysaccharides were also isolated from American ginseng. Immunomodulating glycans, such as water-soluble COLD-FX (CVT-E002), were isolated from the roots of P. quinquifolium [63]. These glycans are poly furanosyl-pyranosylsaccharides. Hypoglycemic glycans, such as quinquefolans A, B, and C, were isolated from the roots of P. quinquifolium [64]. These glycans displayed hypoglycemic effects in normal and alloxan-induced hyperglycemic mice. Polyacetylenes, such as polyacetylene PQ-1, PQ- 2, PQ-3, panaxynol, panaxydol, and 1,8-heptadecadiene- 4,6-diyne-3,10-diol, were isolated from the roots of P. quinquifolium [65-67]. Nakamura et al. [54] isolated three flavonoids and 3 flavonoid glycosides, kaempferol 3-O-β-D-sophoroside-7-O-α-Lrhamnopyranoside, kaempferol-O-(2,3-di-E-p-coumaroyl-α-Lrhamnopyranoside), and kaempferol-3-O-α -L-rhamnopyranoside.

CHEMICAL DIVERSITY OF PANAX NOTOGINSENG

Notoginseng is also commonly used as a traditional Chinese medicine. Notoginseng contains saponins, flavonoids, polyacetylenes, polysaccharides, amino acids, fatty acids, and peptides. Ginsenosides and polysaccharides are notable components in P. notoginseng, just as they are in P. ginseng and P. quinquifolium [68,69]. More than 60 dammarane saponins have been isolated from the roots, rhizome, rootlets, fibers, leaves, flower buds, seeds, and fruit pedicels of Notoginseng. Most of these saponins are ginsenosides and notoginsenosides. However, an oleanolic acid saponin has not been found in Notoginseng. Oleanolic acid saponin occurs commonly in the plant kingdom and can be isolated from both Asian ginseng and American ginseng. The chemical constituents of American ginseng can be distinguished from those of Notoginseng.Yoshikawa et al. [70] and Yoshikawa et al. [71] isolated 9 dammaranetype triterpene glycosides, notoginsenosides-A, -B, -C, -D, -E, -G, -H, -I, and -J, and an acetylenic fatty acid glycoside, notoginsenic acid β-sophoroside. Chen and Sorensen [72] isolated ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, and Rg. Wei et al. [73], Wei et al. [74], and Wei et al. [75] subsequently reported the isolation of ginsenoside Rb1, notoginsenosides-Fc and -Fa, and gypenosides XV and XVII. The genuine aglycones of these ginsenosides are hydrolyzed to panaxadiol and panaxatriol (dammar-20(22)-en-3β,12β,26-triol, and 20R-dammaran-3β,12β,20,25-tetrol) by acidic hydrolysis [76]. Cui et al. [76] isolated two new ginsenosides, notoginsenoside Rw1 [6-O-β-D-xylopranosyl-20-O-β- D-xylopyranosyl-(1-˃6)-β-D-glucopyranosyl-dammar- 24-ene-3b,6a,12b,20(S)tetraol] and Rw2 [6-O-β- Dxylopyranosyl-(1->2)-β-D-glucopyranosyl-dammar- 22-ene-(trans)-3β,6α,12βb,20(S),25-pentaol], from the roots of P. notoginseng. Wan et al. [77] isolated 5,6-didehydroginsenoside Rd, 5,6-didehydroginsenoside Rb1 from the root of P. notoginseng. Liu et al. [78] identified 151 saponins in the root of notoginseng by Esi-Ms, HPLC/ESI-MS(n). Of these, 56 new compounds were identified, although these compounds were not isolated. Recently, Wang et al. [79] isolated 20S-25-methoxyldammarane- 3β,12β,20-trio, a compound that exhibits potent cytotoxicity against tumor cells. Zhao et al. [80] isolated 20(S)-25-OCH3-protopanaxadiol, another cytotoxic compound against tumor cells, from the leaves of P. notoginseng. Wang et al. [81] isolated floranotoginsenosides- A, B, C, and D and 5 known compounds from the flower buds of P. notoginseng. Sun et al. [82] steamed the root of notoginseng and isolated ginsenosides Rg1, Re, Rb1, Rd and notoginsenoside R1 from Notoginseng. As seen on the steaming process of red ginseng, steaming notoginseng increased the contents of ginsenosides Rh1, Rg2, Rg3, Rh2, and 20Rginsenoside Rg2. Teng et al. [83] treated notoginseng roots under a specific mild acidic condition and isolated twenty saponins from them. Five isolated saponins were new dammarane glycosides, and these saponins were named as notoginsenosides T1-T5. Other saponins were the ginsenosides Rg5, Rg2, Rg1, Re, Rh4, Rd, 20Rginsenoside Rg3, ginsenoside Rg3, 20R-ginsenoside Rh1, ginsenoside Rh1, the notoginsenosides E, R2, and R1, the gypenoside XVII, 20R-25-hydroxyginsenoside Rh1, and 20S-25-hydroxyginsenoside Rh1. Sanchinan-A (1.5x106), PF3111, PF3112, PBGA11, and PBGA12 were isolated from Notoginseng. These compounds showed immunostimulating activity [84]. Choi et al. [85] isolated the β-amyloid-induced neurotoxicity-ameliorating constituent, quercetin-3-β-xylopyranosyl-β-D-galactopyranoside, from the root of Notoginseng. Wei et al. [73] isolated quercetin-3-Osophoroside, kaempferol-3-O(2”-β-D-glucopyranosyl)- β-D-galactopyranoside, and quercetin-3-O(2”-β-Dglucopyranosyl)-β-D-galactopyranoside from the leaves of P. notoginseng. Liu et al. [86] isolated polyacetylene compounds, and Chan et al. [87] isolated trilinolein from the roots of P. notoginseng.

METABOLITES OF MAIN CONSTITUENTS AND THEIR BIOLOGICAL ACTIVITIES

When ginseng is orally administered to humans, its main constituents (ginseng saponins and polysaccharides) cannot be easily absorbed from the intestine due to their hydrophilicity. Therefore, these constituents inevitably come into contact with intestinal microflora in the alimentary tract and can be metabolized by intestinal microflora [88,89]. The metabolites are then easily absorbed from the gastrointestinal tract because most of the metabolites are nonpolar. These absorbed metabolites may express pharmacological actions. For example, when the extract of the root of P. ginseng was orally administered to humans, compound K and ginsenosides Rh1 and F1 were detected in the blood [90,91]. Ginsenosides Rb1 and Rb2 were not detected. When ginsenoside Rb1, a main constituent of P. ginseng, was orally administered to conventional rats, compound K was detected in the intestinal contents, blood, and urine [92,93]. Ginsenoside Rb1 was not detected. Furthermore, compound K was detected in the blood and intestinal contents when ginsenoside Rb1 was orally administered to gnotobiotic rats [94]. However, when ginsenoside Rb1 was orally administered to germ-free rats, compound K and ginsenoside Rb1 were not detected in the blood and intestinal contents. When Notoginseng extract, whose main constituents are ginsenoside Ra3, Rb1, Rd, Re, and Rg1 and notoginsenoside R1, was orally administered to rats, the compounds that were mainly absorbed into the blood were ginsenoside Ra2, Rb1, and Rd and compound K [95]. These results are not consistent. Nevertheless, compound K, a metabolites of protopanaxadiol ginsenosides, always are absorbed into the blood. Furthermore, of parental ginsenosides and their metabolites, compound K, ginsenoside Rh1, Rh2, and protopanaxatriol showed the most potent biological effects compared with those of parental compounds. For example, compound K and 20(S)-ginsenoside Rh2 exhibited the most potent cytotoxicity against tumor cells [96,97]. Ginsenoside Rb1 and Rb2 did not exhibit cytotoxicity against the tumor cell lines. However, most ginsenosides have anti-tumor activities in vivo [98,99]. Therefore, the metabolism of ginseng constituents by intestinal microflora is likely to play an important role in the pharmacological activity of ginseng. Protopanaxadiol ginsenosides are metabolized to compound K by human intestinal microflora, such as Bifidobacterium K-110, Bifidobacterium H-1, Provetellaoris, Fusobacterium K-60, Bacteroides JY-6, Eubacterium A-44, and Bifidobacterium K-506 [89]. Protopanaxatriol saponin ginsenosides Re and Rg1 were easily transformed to ginsenoside Rh1 or protopanaxatriol by human intestinal bacteria, such as Fusobacterium K-60, Bacteroides JY-6, Eubacterium A-44, and Bacteroides HJ-15 [100,101].

Compound K

Compound K exhibits chemopreventive [97], chemotherapeutic [102], anti-inflammatory [103], hepatoprotective [92], anti-pruritic [104], antiallergic [105], and hypoglycemic [106] effects in vitro and in vivo. Compound K also reduced stress in mice [107].

Ginsenoside Rh2

Ginsenoside Rh2 showed anti-tumor [99], anti-inflammatory [108], anti-pruritic [109], antiallergic [106], hepatoprotective [110], hypoglycemic, and hypolipidemic effects in mice [111,102]. Ginsenoside Rh2 effectively inhibited adipocyte differentiation via PPAR-γ inhibition [112] and improved insulin sensitivity [113]. Ginsenoside Rh2 ameliorated transient focal ischemia in rats [114].

Ginsenoside Rh1

Ginsenoside Rh1 exhibited anti-inflammatory [115], antiallergic [106], anti-dermatitic [116] effects in vitro and in vivo. Ginsenoside Rh1 showed anticarcinogenic and estrogenic effects [117] and stimulated the secretion of lipoprotein lipase in 3T3-L1 adipocytes [118].

Protopanaxatriol

Protopanaxatriol binds to glucocorticoid and estrogen receptors in endothelial cells and stimulates these receptors [119]. Protopanaxatriol (PPT) also has an estrogenic effect in MCF9 cells [120]. PPT has an adjuvant effect and activates PPARγ in 3T3-L1 adipocytes [121]. PPT also exhibits anti-inflammatory and antiangiogenic effects [122].

ACIDIC POLYSACCHARIDES

Ginseng polysaccharides are also degraded to low molecular weights by heat/steaming processing and intestinal microflora. However, the properties of the degraded molecules have not been clearly studied. Water-soluble polysaccharides and oligosaccharides from Korean ginseng have a number of effects on immune and host defense functions [123]. These glycans activate macrophages, induce IFN-γ and TNF-α production in immune cells, stimulate phagocytosis [124], stimulate natural killer-cell activity [125], and activate components of cell-mediated immunity [126]. Red ginseng acidic polysaccharides restored the proliferation of splenocytes and NK cell activity that had been suppressed by paclitaxel. Additionally, the synergistic effect of RGAP and paclitaxel increased the tumoricidal activity of macrophages [127]. Antirotaviral pectic polysaccharide was isolated from heat-processed ginseng [128].

Industrial application

When ginseng is orally administered to humans, its hydrophilic components inevitably come into contact with intestinal microflora in the alimentary tract and undergo transformation prior to absorption from the gastrointestinal tract. The pharmacological activities of these compounds are then expressed. All individuals possess characteristic indigenous strains of intestinal bacteria. The activities that metabolize these constituents into bioactive compounds that are absorbable from the intestine into the blood differ significantly between individuals. Ginsengs containing bioactive and absorbable metabolites are valuable for treating various diseases. Therefore, fermented and heat-processed ginseng products have recently been released onto the market. Fermentation and heat processing transform hydrophilic components to hydrophobic compounds that can be easily absorbed from the gastrointestinal tract. To develop fermented ginseng, edible microbes, such as probiotics, should be used. Currently, there are few developed fermented ginsengs. Therefore, research related to the biotransformation of ginsenosides is focused on bioactive production. These metabolites, such as ginsenoside compound K, Rh1, Rh2, Rk1, Rh3, Rh4, and protopanaxadiol, are readily absorbed into the blood and express pharmacological effects. These ginsenosides have demonstrated excellent potential for pharmacological use. To develop these ginsenosides, many kinds of microbes isolated from soils or intestinal microflora have been used (Table 2) [129,130].
Table 2.

Ginsenosides transformation by hydrolyzing the sugar moieties in ginsenosides using microbial glycosidases

SubstrateProductMicroorganismEnzymeReference

Ginseng extractC-KBifidobacterium longum H-1β-D-Glucosidase/α-L-Arabinosidase[131]
Ginseng extractSulfolobus solfataricusβ-D-Glycosidase (recombinant: 83)[132]
Ginseng extractAspergillus nigerPectinase (commercial)[133]
Ginseng extractRh2Bifidobacterium longum H-1β-D-Glucosidase (crude)[134]
Ginseng extractRg3Trichoderma reesieCellulase (commercial)[135]
Ra1, Ra2Rb2, RcBifidobacterium breveβ-D-Xylosidase (purified)[136]
Gypenoside-5RdAbsidia sp.α-L-Rhamnosidase (purified)[137]
Rb2Bifidobacterium breveα-L-Arabinopyranosidase (purified)[138]
RcBifidobacterium breveα-L-Arabinopyranosidase (purified)[136]
Rb1Chloroflexus aurantiacusβ-D-Glucosidase (recombinant)[139]
Rb1Cladosprorium fulvumβ-D-Glucosidase (purified)[140]
Rb1, Rb2, RcThermus caldophilusβ-D-Glycosidase (recombinant)[141]
PPD mixtureTrichoderma virideCellulase (commercial)[142]
Rb1, Rb2, RcRg3Penicillium sp.Lactase (commercial)[143]
Rb1 RdPaecilomyces bainierβ-D-Glucosidase (purified)[144]
Rb1, Rb2, RcF2Aspergillus oryzaeLactase (commercial)[142]
Rb1, Rb2, RcPenicillium sp.Lactase (commercial)[143]
Rb1, Rb, RcC-K, C-Y, C-McSulfolobus acidocaldariusβ-D-Glycosidase (recombinant)[132]
Rb1, Rb, Rc,Paecilomyces bainierβ-D-Glucosidase (purified)[145]
Rb1C-KFusobacterium sp.β-D-Glucosidase (purified)[146]
Rb1, Rb2, RcAspergillus oryzaeβ-D-Galactosidase (commercial)[142]
Rb1, Rb2, RcPenicillium sp.Lactase (commercial)[143]
Rb1, Rb2, Rb3, RcAspergillus sp.β-D-Glycosidase (purified)[147]
Rg3Rh2Fusarium proliferatumβ-D-Glucosidase (purified)[148]
ReRg1Penicillium sp.Hesperidinase (commercial)[143]
ReBacterodies sp.α-D-Rhamnosidase (purified)[149]
ReRg2Aspergillus oryzaeβ-Galactosidase (commercial)[142]
ReBacterodies sp.β-D-Glucosidase (purified)[150]
Rg1F1Bacterodies sp.β-D-Glucosidase (purified)[150]
Re, Rg1Penicillium decumbensNaringinase (commercial)[142]
Rg1Rh1Bacterodies sp.β-D-Glucosidase (purified)[150]
Rg2Aspergillus oryzaeβ-Galactosidase (commercial)[143]
Rg2Absidia sp.α-L -Rhamnosidase (purified)[151]
Rg1, Rg2, RfPenicillium sp.Lactase (commercial)[143]
RfAspergillus nigerβ-D-Glucosidase (recombinant)[152]

C-K, compound K; PPD, protopanaxadiol; C-Mc, compound Mc; C-Y, compound Y.

Ginsenosides transformation by hydrolyzing the sugar moieties in ginsenosides using microbial glycosidases C-K, compound K; PPD, protopanaxadiol; C-Mc, compound Mc; C-Y, compound Y. However, most of these biotransformed ginseng extracts are inedible, and most of these microbes may not be safe. Therefore, to develop fermented ginseng extract, we must consider fermented bacteria (Are these bacteria edible?) and safe metabolites (Are these metabolites produced by industrial applied microbes similar to metabolites produced by human intestinal microflora?). Nevertheless, these metabolites are good candidates for new drugs.

CONCLUSION

Korean ginseng, American ginseng, and Notoginseng contain saponins, which are found to be dammarane-type, ocotillol-type and oleanane-type oligoglycosides, and polysaccharides. Of these constituents, dammarane ginsenosides can be metabolized into compound K, ginsenoside Rh1, and protopanaxatriol by intestinal microflora. These metabolites, such as compound K and protopanaxatriol, are pharmacologically active and easily absorbed from the gastrointestinal tract. However, the activities that metabolize these constituents into bioactive compounds differ significantly among individuals. To overcome this challenge, ginsengs have been fermented with enzymes or microbes to produce such metabolites. However, before using these enzymes and probiotics, the safety of these microbes and metabolites must be assessed. The safe ginseng bioproducts produced by enzymes or microbes are valuable for the development of new drugs and/or functional foods.
  131 in total

1.  Six new dammarane-type triterpene saponins from the leaves of Panax ginseng.

Authors:  D Q Dou; Y J Chen; L H Liang; F G Pang; N Shimizu; T Takeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-04       Impact factor: 1.645

Review 2.  Protective effects of trilinolein extracted from panax notoginseng against cardiovascular disease.

Authors:  Paul Chan; G Neil Thomas; Brian Tomlinson
Journal:  Acta Pharmacol Sin       Date:  2002-12       Impact factor: 6.150

3.  Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes.

Authors:  Kyu Lee Han; Myeong Ho Jung; Jong Hee Sohn; Jae-Kwan Hwang
Journal:  Biol Pharm Bull       Date:  2006-01       Impact factor: 2.233

4.  Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer.

Authors:  F Scaglione; F Ferrara; S Dugnani; M Falchi; G Santoro; F Fraschini
Journal:  Drugs Exp Clin Res       Date:  1990

5.  Immunomodulatory activity of Panax ginseng extract.

Authors:  V K Singh; S S Agarwal; B M Gupta
Journal:  Planta Med       Date:  1984-12       Impact factor: 3.352

6.  Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.

Authors:  T Akao; H Kida; M Kanaoka; M Hattori; K Kobashi
Journal:  J Pharm Pharmacol       Date:  1998-10       Impact factor: 3.765

Review 7.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

8.  Sanchinan-A, a reticuloendothelial system activating arabinogalactan from sanchi-ginseng (roots of Panax notoginseng).

Authors:  K Ohtani; K Mizutani; S Hatono; R Kasai; R Sumino; T Shiota; M Ushijima; J Zhou; T Fuwa; O Tanaka
Journal:  Planta Med       Date:  1987-04       Impact factor: 3.352

9.  Ginsenoside Rs(3), a genuine dammarane-glycoside from Korean red ginseng.

Authors:  N I Baek; J M Kim; J H Park; J H Ryu; D S Kim; Y H Lee; J D Park; S I Kim
Journal:  Arch Pharm Res       Date:  1997-06       Impact factor: 4.946

Review 10.  Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds.

Authors:  S Shibata
Journal:  J Korean Med Sci       Date:  2001-12       Impact factor: 2.153

View more
  100 in total

1.  Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects.

Authors:  Tae Woong Cha; Minjoo Kim; Minkyung Kim; Jey Sook Chae; Jong Ho Lee
Journal:  Hypertens Res       Date:  2016-02-04       Impact factor: 3.872

2.  Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.

Authors:  Min Jung Lee; Minhee Jang; Jonghee Choi; Byung Soo Chang; Do Young Kim; Sung-Hoon Kim; Yi-Seong Kwak; Seikwan Oh; Jong-Hwan Lee; Byung-Joon Chang; Seung-Yeol Nah; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-04-07       Impact factor: 5.590

3.  Increased antioxidative and nitric oxide scavenging activity of ginseng marc fermented by Pediococcus acidilactici KCCM11614P.

Authors:  Su Jin Eom; Ji Eun Hwang; Kee-Tae Kim; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2017-09-21       Impact factor: 2.391

4.  Subtractive transcriptome analysis of leaf and rhizome reveals differentially expressed transcripts in Panax sokpayensis.

Authors:  Bhusan Gurung; Pardeep K Bhardwaj; Narayan C Talukdar
Journal:  Funct Integr Genomics       Date:  2016-09-01       Impact factor: 3.410

Review 5.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

6.  Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysis.

Authors:  Chunhao Yu; Chong-Zhi Wang; Chun-Jie Zhou; Bin Wang; Lide Han; Chun-Feng Zhang; Xiao-Hui Wu; Chun-Su Yuan
Journal:  J Pharm Biomed Anal       Date:  2014-07-01       Impact factor: 3.935

7.  Determination of American ginseng saponins and their metabolites in human plasma, urine and feces samples by liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.

Authors:  Jin-Yi Wan; Chong-Zhi Wang; Zhi Liu; Qi-Hui Zhang; Mark W Musch; Marc Bissonnette; Eugene B Chang; Ping Li; Lian-Wen Qi; Chun-Su Yuan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-02-06       Impact factor: 3.205

8.  Paving the Road Toward Exploiting the Therapeutic Effects of Ginsenosides: An Emphasis on Autophagy and Endoplasmic Reticulum Stress.

Authors:  Milad Ashrafizadeh; Shima Tavakol; Reza Mohammadinejad; Zahra Ahmadi; Habib Yaribeygi; Tannaz Jamialahmadi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Ginsenoside Re Protects Trimethyltin-Induced Neurotoxicity via Activation of IL-6-Mediated Phosphoinositol 3-Kinase/Akt Signaling in Mice.

Authors:  Thu-Hien Thi Tu; Naveen Sharma; Eun-Joo Shin; Hai-Quyen Tran; Yu Jeung Lee; Ji Hoon Jeong; Jung Hwan Jeong; Seung Yeol Nah; Hoang-Yen Phi Tran; Jae Kyung Byun; Sung Kwon Ko; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-09-07       Impact factor: 3.996

10.  Immunomodulatory effect of a formula developed from American ginseng and Chinese jujube extracts in mice.

Authors:  Zhuo-ping Yu; Dong-dong Xu; Lai-feng Lu; Xiao-dong Zheng; Wei Chen
Journal:  J Zhejiang Univ Sci B       Date:  2016-02       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.